Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024
Presentation Miami Valves 2024 Depressed Ventricular Function, Shock and Aortic Stenosis Presenter: Diego H. González-Bravo February 01, 2024
Presentation Miami Valves 2024 Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock Presenter: Victor Razuk February 01, 2024
Presentation TCT 2020 IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction) Presenter: Rodrigo Estévez-Loureiro October 17, 2020
Presentation TCT 2019 TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes) Presenter: David Hildick-Smith September 26, 2019
Presentation TCT 2019 AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome Presenter: Stephan Windecker September 26, 2019
Presentation IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective Presenter: David Cox April 11, 2019
Presentation Cardiovascular Interventions 2018 Show me the Data: Key Clinical Trials of 2018 Presenter: Ehtisham Mahmud October 26, 2018
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2017 Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy Presenter: Vasilis Babaliaros, Shmuel Banai, Andrew Wechsler October 30, 2017
Presentation Cardiovascular Interventions 2016 Unprotected Left Main Stenting Presenter: Paul S. Teirstein November 10, 2016
Presentation TCT 2016 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy November 01, 2016
Presentation TCT 2016 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White November 01, 2016
Presentation TCT 2016 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers November 01, 2016
Presentation TCT 2016 Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad November 01, 2016
Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant October 30, 2016